Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin

Revision as of 13:32, 5 June 2009 by Raquel Suarez (talk | contribs) (New page: Complete Title of Study Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin [edit] Study Acronym (The trial's abbreviation if there is one)...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Complete Title of Study

Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin

[edit] Study Acronym (The trial's abbreviation if there is one) None reported

[edit] Principal Investigator, Co-investigators, and Collaborating Institutions None reported

[edit] Overview of Trial None reported

[edit] Disease State(s) Studied (e.g. acute MI, breast cancer, etc.) None reported

[edit] Study Phase (e.g. Phase I,II,III,IV) Study Phases are defined here None reported

[edit] Study Design (e.g. multicenter, randomized, double blind, placebo controlled) None reported

[edit] Study Arms and How They Were Treated (Intervention) (Explanation here) None reported

[edit] Primary Pre-Specified Endpoint None reported

[edit] Secondary Endpoints None reported

[edit] Inclusion Criteria None reported

[edit] Exclusion Criteria None reported

[edit] Outcome: Primary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available) None reported

[edit] Outcome: Secondary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available) None reported

[edit] Outcome: Exploratory endpoints (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available) None reported

[edit] Outcome: Safety endpoints (Report both relative risk and absolute risk as well as number needed to harm if available) None reported

[edit] Conclusions of the Investigators (Quote the investigators conclusions here) None reported

[edit] Commentary, Discussion and Limitations of the Trial (Anyone can add comments) None reported

[edit] Slides None reported

[edit] Video Commentary None reported

[edit] References (How to insert a reference) None reported

[edit] External sites for further information (How to insert links) None reported

[edit] Detailed information about the trial [edit] Ages __ years to ___ years

[edit] Gender (Indicate whether men, women or both were enrolled) None reported

[edit] Accepts Healthy Volunteers (Answer yes or no) None reported

[edit] Enrollment Period (Study start and end date) None reported

[edit] Recruitment Status (explanation) None reported

[edit] Enrollment (Total number of patients enrolled) None reported

[edit] Study Sponsor (e.g. Investigator initiated or company name) None reported (this may not have yet been ascertained)

[edit] Source of Data (Where is this data on this page coming from: publication, principal investigator, or co-investigator)